Clinical Trial Update: Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects [Phase 3]

View source ↗

Summary

Phase 3 results summarize the efficacy and safety of a combined oral contraceptive containing estradiol valerate and dienogest in healthy female subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• Estradiol valerate/dienogest (Estradiol valerate and dienogest)

Snippet

Sponsor: Bayer | Conditions: Contraception | Phase 3 | Status: COMPLETED